Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology

Anthe S. Zandvliet, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema

Onderzoeksoutput: Bijdrage aan tijdschriftArtikel recenserenpeer review

36 Citaten (Scopus)


Population pharmacokinetic and pharmacodynamic analysis is an important tool to support optimal treatment in clinical oncology. The population approach is suitable to explain variability between patients and to establish relationships between drug exposure and a relevant pharmacodynamic parameter. This can facilitate the selection of dosing schedules, the development of strategies for dose individualization and the application of therapeutic drug monitoring of anticancer agents. This review discusses the role of population pharmacokinetics and pharmacodynamics in clinical oncology to enhance the efficiency of drug development and to support the development of safe and effective dosing regimens for optimal treatment of cancer patients. An overview of published population studies of investigational anticancer agents and established treatment regimens is presented.

Originele taal-2Engels
Pagina's (van-tot)487-513
Aantal pagina's27
TijdschriftClinical Pharmacokinetics
Nummer van het tijdschrift8
StatusGepubliceerd - 2008
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Population pharmacokinetics and pharmacodynamics for treatment optimization in clinical oncology'. Samen vormen ze een unieke vingerafdruk.

Citeer dit